Skip to main content
. 2020 Jun 3;4(11):2451–2459. doi: 10.1182/bloodadvances.2019001311

Table 1.

Baseline characteristics of JOS-C study participants at the time of JOS study exit (age 6 y)

Baseline characteristics at age 6 y Early prophylaxis Delayed prophylaxis P
Participants in analysis, n 15 18
Age of prophylaxis initiation, mean (SD), y 1.3 (0.4) 7.6 (3.5) <.0001
MRI OC damage, n/N (%)
 Boys with OC damage 1/15 (6.7) 9/18 (50) .020
 Joints with OC damage 1/89 (1) 9/102 (9) .021
No MRI damage, eMRI score < 1, n/N (%)
 Boys with no damage 11/15 (73) 6/18 (33) .022
 Joints with no damage 85/89 (96) 81/102 (79) .001
eMRI, median (IQR) of participant joint averages
 MRI score 0.08 (0-0.3) 0.6 (0.02-1.7) .07
 OC MRI score 0 (0-0) 1.2 (0.3-3.1) .05
ABR prior to age 6 y, mean (SD)
 Joint ABR 0.7 (0.8) 3.8 (2.8) .0002
 ABR 3.2 (3.1) 14.4 (6.6) .0072
CPJAS, average per joint, mean (SD)
 Physical examination score 1.0 (0.9) 1.7 (1.4) .094

Numbers expressed as mean (SD) or median (IQR) for continuous variables depending on normal or skewed distribution, and number (percentage) for count variables. Maximum CPJAS score, 31 points per joint; maximum MRI score, 45 per joint; maximum OC score, 36 per joint.

OC, osteochondral.